Identification of mechanisms by which cGAS/STING signaling is suppressed in CRC and find ways to restore or enhance cGAS/STING expression and activation would improve efficacy of FOLFOX, anti-PD-1/PD-L1 or their combination and overcome resistance. This evidence concerns the gene STING1 and colorectal carcinoma.